美股詳情

本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務

猴痘概念

1,551.80

+8.540.55%

漲家數：9

跌家數：3

平家數：- -

市盈率：- -

高：1,575.99

開：1,545.17

低：1,541.96

收：1,543.26

資料載入中...

總覽新聞資訊

美股抗疫概念股集體上漲，Moderna漲近16%

每日经济新闻

美國 FDA 擴大 ARS 製藥公司過敏反應鼻噴霧劑在 15-30 公斤患者中的使用範圍

美國 FDA 擴大過敏反應鼻腔噴霧劑在 15-30 公斤體重人羣中的使用範圍

Aethlon Medical, Inc.盤中異動下午盤快速上漲5.68%

Emergent Biosolutions Inc.盤中異動快速下挫5.01%

Chimerix, Inc.股價拉昇69.46% 市值漲5.25億美元

BUZZ-Chimerix 因爵士製藥公司以 9.35 億美元收購而大漲

爵士製藥公司將以 9.35 億美元收購 Chimerix 公司

伊諾維奧製藥盤中異動急速拉昇5.43%

Applied Dna Sciences, Inc.盤中異動大幅跳水6.27%

Geovax Labs, Inc.盤中異動早盤股價大漲5.96%

Emergent Biosolutions Inc.股價重挫15.96% 市值跌4963.83萬美元

BUZZ-Emergent BioSolutions 因季度收入下降而下跌

Emergent BioSolutions Inc 報告截至 12 月 31 日的季度業績 - 收益摘要

Emergent BioSolutions Inc 報告截至 12 月 31 日的季度業績 - 收益摘要

BUZZ-Emergent BioSolutions 公佈季度收入不佳後下跌

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/stock/BK4583/news"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"BK4583"},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK4583\",,,,,undefined,":{"symbol":"BK4583","market":"US","secType":"PLATE","nameCN":"猴痘概念","latestPrice":1551.8009,"timestamp":1741208399999,"preClose":1543.2614,"halted":0,"volume":166837424,"delay":0,"changeRate":0.005533,"change":8.539551,"pbRate":3.824438,"amount":3385093748.92931,"amplitude":0.02205,"prevYearClose":1284.7982,"fiveDayClose":1514.4326,"twentyDayClose":1341.489,"turnoverRate":0.059436,"marketCap":175802911591.5,"floatMarketCap":175019023106.5,"peRate":756.174276},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK4583\",,,,,undefined,":{"symbol":"BK4583","high":1575.9855,"amplitude":0.02205,"preClose":1543.2614,"low":1541.9567,"pbRate":"3.824438","latestPrice":1551.8009,"volume":166837424,"delay":0,"open":1545.173,"prevYearClose":1284.7982,"prevWeekClose":1535.672,"prevMonthClose":1535.672,"prevQuarterClose":1284.7982,"fiveDayClose":1514.4326,"twentyDayClose":1341.489,"sixtyDayClose":1289.8053,"secType":"PLATE","market":"US","turnoverRate":0.059436,"peRate":756.174276,"marketCap":175802911591.5,"floatMarketCap":175019023106.5,"timestamp":1741208399999,"nameCN":"猴痘概念"},"@#url:\"https://hq.skytigris.cn/api/global/plate/up_down\",method:\"POST\",data:#delay:false,bkCodes:@\"BK4583\",,,,undefined,":{"bkCode":"BK4583","up":9,"down":3,"flat":0},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BK4583\",pageSize:16,pageCount:1,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2517920878","title":"美股抗疫概念股集體上漲，Moderna漲近16%","url":"https://stock-news.laohu8.com/highlight/detail?id=2517920878","media":"每日经济新闻","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517920878?lang=zh_tw&edition=fundamental","pubTime":"2025-03-06 05:54","pubTimestamp":1741211660,"startTime":"0","endTime":"0","summary":"每经AI快讯，周三（3月5日），美股抗疫概念股集体上涨，Moderna涨近16%，吉利德科学涨0.61%，诺瓦瓦克斯医药涨超2%，BioNTech涨逾4%，阿斯利康涨0.92%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202503063337642255.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202503063337642255.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["BK4550","BK4547","IE0002270589.USD","LU0234570918.USD","LU2089984988.USD","BK4566","IE00BSNM7G36.USD","LU1066051498.USD","LU1839511570.USD","BK4588","GILD","IE00B19Z3B42.SGD","LU1430594728.SGD","BK4568","LU0889565916.HKD","LU1066053197.SGD","IE00B7SZLL34.SGD","LU1585245621.USD","BK4583","IE00BZ1G4Q59.USD","BK4139","IE00B19Z3581.USD","LU0058720904.USD","BK4532","LU2468319806.SGD","LU0289739699.SGD","BK4585","IE00B3T34201.USD","IE00BKVL7J92.USD","LU0109394709.USD","LU0320765992.SGD","LU1571399168.USD","NVAX","LU2087621335.USD","BK4578"],"gpt_icon":0},{"id":"2517921276","title":"美國 FDA 擴大 ARS 製藥公司過敏反應鼻噴霧劑在 15-30 公斤患者中的使用範圍","url":"https://stock-news.laohu8.com/highlight/detail?id=2517921276","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517921276?lang=zh_tw&edition=fundamental","pubTime":"2025-03-06 05:21","pubTimestamp":1741209699,"startTime":"0","endTime":"0","summary":"更新版 2-美国 FDA 扩大 ARS 制药公司过敏反应鼻喷雾剂在 15-30 公斤患者中的使用范围第 7-9 段增加了分析师评论；第 11 和 12 段增加了首席执行官评论，并在全文中提供了详细信息Christy Santhosh路透社3月5日 - 美国食品和药物管理局批准扩大ARS制药公司SPRY.O鼻腔喷雾剂的使用范围，用于体重在15至30公斤之间的严重过敏反应患者。ARS 表示，neffy 1 毫克有望于 5 月底在美国上市。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250305:nL3S3PO1U4:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["VTRS","BK4007","BK4585","LU1839511570.USD","SPRY","BK4139","BK4588","BK4583","LU2087621335.USD"],"gpt_icon":0},{"id":"2517921146","title":"美國 FDA 擴大過敏反應鼻腔噴霧劑在 15-30 公斤體重人羣中的使用範圍","url":"https://stock-news.laohu8.com/highlight/detail?id=2517921146","media":"路透中文","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517921146?lang=zh_tw&edition=fundamental","pubTime":"2025-03-06 05:14","pubTimestamp":1741209261,"startTime":"0","endTime":"0","summary":"美国 FDA 扩大过敏反应鼻腔喷雾剂在 15-30 公斤体重人群中的使用范围路透社3月5日 - 美国食品和药物管理局批准扩大ARS制药公司SPRY.O鼻腔喷雾剂的使用范围，用于体重在15至30公斤之间的严重过敏反应患者。 (为便利非英文母语者，路透将其报导自动化翻译为数种其他语言。由于自动化翻译可能有误，或未能包含所需语境，路透不保证自动化翻译文本的准确性，仅是为了便利读者而提供自动化翻译。对于因为使用自动化翻译功能而造成的任何损害或损失，路透不承担任何责任。)","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250305:nL3S3PO1TO:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4588","BK4139","VTRS","SPRY","BK4007","BK4583","LU1839511570.USD","BK4585","LU2087621335.USD"],"gpt_icon":0},{"id":"2517923758","title":"Aethlon Medical, Inc.盤中異動 下午盤快速上漲5.68%","url":"https://stock-news.laohu8.com/highlight/detail?id=2517923758","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517923758?lang=zh_tw&edition=fundamental","pubTime":"2025-03-06 03:15","pubTimestamp":1741202125,"startTime":"0","endTime":"0","summary":"北京时间2025年03月06日03时15分，Aethlon Medical, Inc.股票出现波动，股价大幅上涨5.68%。Aethlon Medical, Inc.股票所在的医疗器械行业中，整体涨幅为1.24%。其相关个股中，Xylo Technologies Ltd、Trisalus Life Sciences Inc C/Wts 10/08/28 、Intelligent Bio Solutions Inc.涨幅较大，古特拉、908 Devices Inc.、Tivic Health Systems, Inc.较为活跃，换手率分别为69.52%、30.77%、10.75%，振幅较大的相关个股有Pavmed Inc C/Wts 30/04/2025 Class Z、Ainos, Inc.、Heartsciences Inc.，振幅分别为40.00%、34.75%、23.28%。Aethlon Medical, Inc.公司简介：Aethlon Medical Inc 是一家医疗技术公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250306031525963b19c1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250306031525963b19c1&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4082","BK4583","AEMD","BK4568"],"gpt_icon":0},{"id":"2517941659","title":"Emergent Biosolutions Inc.盤中異動 快速下挫5.01%","url":"https://stock-news.laohu8.com/highlight/detail?id=2517941659","media":"市场透视","labels":["merge"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517941659?lang=zh_tw&edition=fundamental","pubTime":"2025-03-06 00:21","pubTimestamp":1741191716,"startTime":"0","endTime":"0","summary":"北京时间2025年03月06日00时21分，Emergent Biosolutions Inc.股票出现异动，股价快速跳水5.01%。截至发稿，该股报6.07美元/股，成交量44.1824万股，换手率0.81%，振幅6.53%。Emergent Biosolutions Inc.股票所在的制药行业中，整体涨幅为0.29%。其相关个股中，Organogenesis Holdings Inc.、坎伯兰药业、Quantum Biopharma Ltd.涨幅较大，Painreform Ltd.、Petros Pharmaceuticals, Inc.、Quantum Biopharma Ltd.较为活跃，换手率分别为16.79%、10.67%、5.90%，振幅较大的相关个股有坎伯兰药业、Alpha Teknova, Inc.、Medicus Pharma Ltd.，振幅分别为27.93%、16.89%、14.66%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250306002156a260e73e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250306002156a260e73e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"merge","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BK4583","EBS"],"gpt_icon":0},{"id":"2517910040","title":"Chimerix, Inc.股價拉昇69.46% 市值漲5.25億美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2517910040","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517910040?lang=zh_tw&edition=fundamental","pubTime":"2025-03-05 22:31","pubTimestamp":1741185073,"startTime":"0","endTime":"0","summary":"北京时间2025年03月05日22时31分，Chimerix, Inc.股票出现波动，股价急速拉升69.46%。截至发稿，该股报8.41美元/股，成交量6116.51万股，换手率67.98%，振幅0.20%。Chimerix, Inc.股票所在的生物技术行业中，整体涨幅为0.08%。Chimerix, Inc.公司简介：Chimerix Inc.是一家总部位于美国的生物制药公司，从事药物的研究，开发和商业化。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250305223113a260c70a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250305223113a260c70a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CMRX","BK4139","BK4583"],"gpt_icon":0},{"id":"2517916635","title":"BUZZ-Chimerix 因爵士製藥公司以 9.35 億美元收購而大漲","url":"https://stock-news.laohu8.com/highlight/detail?id=2517916635","media":"路透中文","labels":["corporation","merge"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517916635?lang=zh_tw&edition=fundamental","pubTime":"2025-03-05 20:37","pubTimestamp":1741178279,"startTime":"0","endTime":"0","summary":"** CMRX 在过去 12 个月中上涨了 320(为便利非英文母语者，路透将其报导自动化翻译为数种其他语言。由于自动化翻译可能有误，或未能包含所需语境，路透不保证自动化翻译文本的准确性，仅是为了便利读者而提供自动化翻译。对于因为使用自动化翻译功能而造成的任何损害或损失，路透不承担任何责任。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250305:nL3T3PO15C:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"corporation,merge","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4583","BK4139","LU0823416689.USD","BK4532","BK4007","IE00BN0W2T93.GBP","IE00BN0W2V16.EUR","IE00BN0W2W23.USD","LU0320765992.SGD","LU0109394709.USD","BK4533","JAZZ","LU0889565916.HKD","CMRX"],"gpt_icon":0},{"id":"2517274913","title":"爵士製藥公司將以 9.35 億美元收購 Chimerix 公司","url":"https://stock-news.laohu8.com/highlight/detail?id=2517274913","media":"路透中文","labels":["corporation","merge"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517274913?lang=zh_tw&edition=fundamental","pubTime":"2025-03-05 20:06","pubTimestamp":1741176397,"startTime":"0","endTime":"0","summary":"爵士制药公司将以 9.35 亿美元收购 Chimerix 公司路透社3月5日 - 爵士制药公司JAZZ.O与Chimerix公司>周三表示，两家公司将以约9.35亿美元的价格收购Chimerix公司，以获得其治疗一种罕见脑瘤的实验性药物。(为便利非英文母语者，路透将其报导自动化翻译为数种其他语言。由于自动化翻译可能有误，或未能包含所需语境，路透不保证自动化翻译文本的准确性，仅是为了便利读者而提供自动化翻译。对于因为使用自动化翻译功能而造成的任何损害或损失，路透不承担任何责任。)","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250305:nL3S3PO134:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"corporation,merge","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0109394709.USD","BK4007","LU0320765992.SGD","BK4583","LU0889565916.HKD","LU0823416689.USD","CMRX","BK4532","BK4139","IE00BN0W2V16.EUR","IE00BN0W2T93.GBP","IE00BN0W2W23.USD","JAZZ","BK4533"],"gpt_icon":0},{"id":"2517985310","title":"伊諾維奧製藥盤中異動 急速拉昇5.43%","url":"https://stock-news.laohu8.com/highlight/detail?id=2517985310","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517985310?lang=zh_tw&edition=fundamental","pubTime":"2025-03-05 04:20","pubTimestamp":1741119617,"startTime":"0","endTime":"0","summary":"北京时间2025年03月05日04时20分，伊诺维奥制药股票出现波动，股价急速拉升5.43%。截至发稿，该股报1.94美元/股，成交量49.8997万股，换手率1.38%，振幅7.07%。机构评级方面，目前暂无机构对该股做出“买入、持有、卖出”建议。伊诺维奥制药股票所在的生物技术行业中，整体涨幅为0.13%。伊诺维奥制药公司简介：Inovio Pharmaceuticals Inc是一家总部位于美国的生物技术公司，致力于开发基于DNA的活性免疫疗法和疫苗，以治疗和预防癌症和传染病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250305042017abe85268&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250305042017abe85268&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4568","BK4583","BK4139","INO"],"gpt_icon":0},{"id":"2516067008","title":"Applied Dna Sciences, Inc.盤中異動 大幅跳水6.27%","url":"https://stock-news.laohu8.com/highlight/detail?id=2516067008","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2516067008?lang=zh_tw&edition=fundamental","pubTime":"2025-03-04 22:48","pubTimestamp":1741099724,"startTime":"0","endTime":"0","summary":"北京时间2025年03月04日22时48分，Applied Dna Sciences, Inc.股票出现异动，股价急速跳水6.27%。Applied Dna Sciences, Inc.股票所在的生命科学行业中，整体跌幅为0.75%。Applied Dna Sciences, Inc.公司简介：Applied DNA Sciences Inc 是一家开发和商业化生产和检测脱氧核糖核酸和核糖核酸技术的生物技术公司。该公司以Applied DNA Sciences、SigNature分子标签、SigNature T分子标签、fiberTyping、SigNify等品牌提供的产品和服务。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250304224844abe7f543&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250304224844abe7f543&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4505","RNA","DNA","BK4585","BK4121","BK4139","APDN","BK4583","BK4109","BK4196","BK4588","BDSX"],"gpt_icon":0},{"id":"2516773526","title":"Geovax Labs, Inc.盤中異動 早盤股價大漲5.96%","url":"https://stock-news.laohu8.com/highlight/detail?id=2516773526","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2516773526?lang=zh_tw&edition=fundamental","pubTime":"2025-03-04 22:43","pubTimestamp":1741099393,"startTime":"0","endTime":"0","summary":"北京时间2025年03月04日22时43分，Geovax Labs, Inc.股票出现异动，股价快速拉升5.96%。Geovax Labs, Inc.股票所在的生物技术行业中，整体涨幅为0.35%。Geovax Labs, Inc.公司简介：Geovax Labs Inc 是一家临床阶段的生物技术公司，利用新型专有平台开发针对传染病和实体瘤癌症的人类疫苗和免疫疗法。GeoVax 的产品线包括正在进行的下一代 COVID-19疫苗的人体临床试验和针对头颈癌的基因导向疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025030422431496394835&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025030422431496394835&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4583","GOVX","BK4139"],"gpt_icon":0},{"id":"2516677553","title":"Emergent Biosolutions Inc.股價重挫15.96% 市值跌4963.83萬美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2516677553","media":"市场透视","labels":["merge"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2516677553?lang=zh_tw&edition=fundamental","pubTime":"2025-03-04 22:32","pubTimestamp":1741098779,"startTime":"0","endTime":"0","summary":"北京时间2025年03月04日22时32分，Emergent Biosolutions Inc.股票出现异动，股价快速下跌15.96%。截至发稿，该股报5.74美元/股，成交量35.3898万股，换手率0.65%，振幅4.39%。Emergent Biosolutions Inc.股票所在的制药行业中，整体跌幅为0.02%。Emergent Biosolutions Inc.公司简介：Emergent BioSolutions Inc 向政府和医疗保健提供者提供公共卫生产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250304223259abe7f004&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250304223259abe7f004&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"merge","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","EBS","BK4583"],"gpt_icon":0},{"id":"2516288673","title":"BUZZ-Emergent BioSolutions 因季度收入下降而下跌","url":"https://stock-news.laohu8.com/highlight/detail?id=2516288673","media":"路透中文","labels":["dataReport","merge"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2516288673?lang=zh_tw&edition=fundamental","pubTime":"2025-03-04 20:42","pubTimestamp":1741092154,"startTime":"0","endTime":"0","summary":"3月4日 -  ** 制药商Emergent BioSolutions EBS.N股价盘前下跌13.8%至5.9美元  ** 周一晚些时候，该公司在 ，第四季度营收为1.947亿美元，低于去年同期的2.766亿美元。** 股价在过去 12 个月中上涨了一倍多(为便利非英文母语者，路透将其报导自动化翻译为数种其他语言。由于自动化翻译可能有误，或未能包含所需语境，路透不保证自动化翻译文本的准确性，仅是为了便利读者而提供自动化翻译。对于因为使用自动化翻译功能而造成的任何损害或损失，路透不承担任何责任。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250304:nL3S3PN16S:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport,merge","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["EBS","BK4139","BK4583"],"gpt_icon":0},{"id":"2516769546","title":"Emergent BioSolutions Inc 報告截至 12 月 31 日的季度業績 - 收益摘要","url":"https://stock-news.laohu8.com/highlight/detail?id=2516769546","media":"路透中文","labels":["merge"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2516769546?lang=zh_tw&edition=fundamental","pubTime":"2025-03-04 08:54","pubTimestamp":1741049653,"startTime":"0","endTime":"0","summary":"Emergent BioSolutions Inc 报告截至 12 月 31 日的季度业绩 - 收益摘要Emergent BioSolutions Inc EBS.N报告了截至12月31日的季度调整后每股收益5美分，高于去年同期的每股收益-77美分。Emergent BioSolutions 公司公布的本季度每股收益为亏损 58 美分。该公司当季亏损3130万美元。本季度，Emergent BioSolutions Inc 的股价下跌了 21.8%。华尔街对 Emergent BioSolutions Inc 的 12 个月目标价中位数为 13.50 美元。本摘要由 LSEG 3 月 4 日上午 12:53 时的数据机器生成。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250304:nL3S3PN03U:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"merge","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","EBS","BK4583"],"gpt_icon":0},{"id":"2516462695","title":"Emergent BioSolutions Inc 報告截至 12 月 31 日的季度業績 - 收益摘要","url":"https://stock-news.laohu8.com/highlight/detail?id=2516462695","media":"路透中文","labels":["merge"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2516462695?lang=zh_tw&edition=fundamental","pubTime":"2025-03-04 08:54","pubTimestamp":1741049653,"startTime":"0","endTime":"0","summary":"Emergent BioSolutions Inc 报告截至 12 月 31 日的季度业绩 - 收益摘要Emergent BioSolutions Inc EBS.N报告了截至12月31日的季度调整后每股收益5美分，高于去年同期的每股收益-77美分。Emergent BioSolutions 公司公布的本季度每股收益为亏损 58 美分。该公司当季亏损3130万美元。本季度，Emergent BioSolutions Inc 的股价下跌了 21.8%。华尔街对 Emergent BioSolutions Inc 的 12 个月目标价中位数为 13.50 美元。本摘要由 LSEG 3 月 4 日上午 12:53 时的调制解调器器生成。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250304:nL3T3PN03U:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"merge","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4583","EBS","BK4139"],"gpt_icon":0},{"id":"2516661457","title":"BUZZ-Emergent BioSolutions 公佈季度收入不佳後下跌","url":"https://stock-news.laohu8.com/highlight/detail?id=2516661457","media":"路透中文","labels":["merge"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2516661457?lang=zh_tw&edition=fundamental","pubTime":"2025-03-04 06:11","pubTimestamp":1741039865,"startTime":"0","endTime":"0","summary":"BUZZ-Emergent BioSolutions 公布季度收入不佳后下跌3月3日 -  ** Emergent BioSolutions EBS.N股价在延时交易中下跌12.5%，至5.98美元，为9月份以来最低点 ** 公司报告第四季度收入下降，为1.947亿美元，低于去年同期的2.766亿美元 ** 经调整后，公司每股收益为 5 美分，而去年同期亏损 77 美分 ** 公司正在推进扭亏为盈活动，这是其多年转型计划的关键阶段 - EBS ** 公司股价在 2024 年上涨 298.3(为便利非英文母语者，路透将其报导自动化翻译为数种其他语言。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250303:nL3S3PM1NZ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"merge","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4583","BK4139","EBS"],"gpt_icon":0}],"pageSize":16,"totalPage":4,"pageCount":1,"totalSize":59}]}}